The results showed that the expression of pro-apoptosis proteins Bad and fasL was significantly decreased, and the expression of anti-apoptosis proteins BCL-XL and BCL-2 was significantly increased in PBMCs of patients with T1DM. This evidence concerns the gene BCL2 and type 1 diabetes mellitus.